<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/" >

<channel>
	<title>New Jersey 101.5 &#187; Merck</title>
	<atom:link href="http://nj1015.com/tags/merck/feed/" rel="self" type="application/rss+xml" />
	<link>http://nj1015.com</link>
	<description>New Jersey News</description>
	<lastBuildDate>Wed, 19 Jun 2013 22:45:55 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Shares of Merck, Bristol Jump on Cancer Drug News</title>
		<link>http://nj1015.com/shares-of-merck-bristol-jump-on-cancer-drug-news/</link>
		<comments>http://nj1015.com/shares-of-merck-bristol-jump-on-cancer-drug-news/#comments</comments>
		<pubDate>Mon, 03 Jun 2013 21:29:50 +0000</pubDate>
		<dc:creator>Townsquare News Network</dc:creator>
				<category><![CDATA[Townsquare News Network]]></category>
		<category><![CDATA[Bristol-Myers Squibb]]></category>
		<category><![CDATA[Cancer drugs]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[national]]></category>
		<category><![CDATA[NJ]]></category>
		<category><![CDATA[njsyndicated]]></category>
		<category><![CDATA[stocks]]></category>

		<guid isPermaLink="false">http://nj1015.com/?p=274099</guid>
		<description><![CDATA[Shares of Bristol-Myers Squibb Inc. and Merck &#38; Co. gained about 4 percent each after the drugmakers announced encouraging results on experimental cancer medicines over the weekend. Both companies&#8217; drugs for advanced cases of melanoma are in a new class that helps the patient&#8217;s immune system identify and destroy tumor cells that otherwise would evade [...]]]></description>
			<content:encoded><![CDATA[<p>Shares of Bristol-Myers Squibb Inc. and Merck &amp; Co. gained about 4 percent each after the drugmakers announced encouraging results on experimental cancer medicines over the weekend.
<p class="more_act text"><a href="http://nj1015.com/shares-of-merck-bristol-jump-on-cancer-drug-news/" title="Shares of Merck, Bristol Jump on Cancer Drug News">Read More</a><em>|</em><a href="http://nj1015.com/shares-of-merck-bristol-jump-on-cancer-drug-news/#comments_wrap" title="Shares of Merck, Bristol Jump on Cancer Drug News">Comment</a></p>
]]></content:encoded>
			<wfw:commentRss>http://nj1015.com/shares-of-merck-bristol-jump-on-cancer-drug-news/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	<media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://wac.450F.edgecastcdn.net/80450F/nj1015.com/files/2013/06/Drugs3-300x200.jpg" height="200" width="300" />	</item>
		<item>
		<title>FDA Panel Backs Experimental Merck Insomnia Drug</title>
		<link>http://nj1015.com/fda-panel-backs-experimental-merck-insomnia-drug/</link>
		<comments>http://nj1015.com/fda-panel-backs-experimental-merck-insomnia-drug/#comments</comments>
		<pubDate>Wed, 22 May 2013 21:12:01 +0000</pubDate>
		<dc:creator>Townsquare News Network</dc:creator>
				<category><![CDATA[Townsquare News Network]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[insomnia drug]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[national]]></category>
		<category><![CDATA[NJ]]></category>
		<category><![CDATA[njsyndicated]]></category>

		<guid isPermaLink="false">http://nj1015.com/?p=269863</guid>
		<description><![CDATA[A federal panel of medical experts says that an experimental insomnia drug from Merck &#38; Co Inc. appears safe and effective, despite evidence from company trials that the pill can cause daytime sleepiness and difficulty driving. A majority of panelists on the Food and Drug Administration panel voted that Merck&#8217;s sleeping aid, suvorexant, helped patients [...]]]></description>
			<content:encoded><![CDATA[<p>A federal panel of medical experts says that an experimental insomnia drug from Merck &amp; Co Inc. appears safe and effective, despite evidence from company trials that the pill can cause daytime sleepiness and difficulty driving.
<p class="more_act text"><a href="http://nj1015.com/fda-panel-backs-experimental-merck-insomnia-drug/" title="FDA Panel Backs Experimental Merck Insomnia Drug">Read More</a><em>|</em><a href="http://nj1015.com/fda-panel-backs-experimental-merck-insomnia-drug/#comments_wrap" title="FDA Panel Backs Experimental Merck Insomnia Drug">Comment</a></p>
]]></content:encoded>
			<wfw:commentRss>http://nj1015.com/fda-panel-backs-experimental-merck-insomnia-drug/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	<media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://wac.450F.edgecastcdn.net/80450F/nj1015.com/files/2012/02/Merck.jpg" height="465" width="620" /><media:description xmlns:media="http://search.yahoo.com/mrss/">Getty Images</media:description>	</item>
		<item>
		<title>Lawsuit Alleges Merck Discrimination Against Women</title>
		<link>http://nj1015.com/lawsuit-alleges-merck-discrimination-against-women/</link>
		<comments>http://nj1015.com/lawsuit-alleges-merck-discrimination-against-women/#comments</comments>
		<pubDate>Thu, 09 May 2013 22:44:42 +0000</pubDate>
		<dc:creator>Townsquare News Network</dc:creator>
				<category><![CDATA[Townsquare News Network]]></category>
		<category><![CDATA[discrimination lawsuit]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[NJ]]></category>
		<category><![CDATA[Whitehouse Station]]></category>

		<guid isPermaLink="false">http://nj1015.com/?p=264354</guid>
		<description><![CDATA[A Merck &#38; Co. sales representative is suing the drugmaker for at least $100 million, saying Merck doesn&#8217;t give women equal opportunities for advancement and punishes employees for taking maternity leave. Kelli Smith, a Merck employee since 2004, says the company&#8217;s sales plans create incentives to discriminate against women, that women are told they have [...]]]></description>
			<content:encoded><![CDATA[<p>A Merck &amp; Co. sales representative is suing the drugmaker for at least $100 million, saying Merck doesn't give women equal opportunities for advancement and punishes employees for taking maternity leave.
<p class="more_act text"><a href="http://nj1015.com/lawsuit-alleges-merck-discrimination-against-women/" title="Lawsuit Alleges Merck Discrimination Against Women">Read More</a><em>|</em><a href="http://nj1015.com/lawsuit-alleges-merck-discrimination-against-women/#comments_wrap" title="Lawsuit Alleges Merck Discrimination Against Women">Comment</a></p>
]]></content:encoded>
			<wfw:commentRss>http://nj1015.com/lawsuit-alleges-merck-discrimination-against-women/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	<media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://wac.450F.edgecastcdn.net/80450F/nj1015.com/files/2013/05/Merck-300x2251.jpg" height="225" width="300" />	</item>
		<item>
		<title>Merck&#039;s Ragweed Allergy Therapy Under FDA Review</title>
		<link>http://nj1015.com/mercks-ragweed-allergy-therapy-under-fda-review/</link>
		<comments>http://nj1015.com/mercks-ragweed-allergy-therapy-under-fda-review/#comments</comments>
		<pubDate>Thu, 09 May 2013 01:20:04 +0000</pubDate>
		<dc:creator>Townsquare News Network</dc:creator>
				<category><![CDATA[Townsquare News Network]]></category>
		<category><![CDATA[allergy therapy]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[national]]></category>
		<category><![CDATA[NJ]]></category>
		<category><![CDATA[njsyndicated]]></category>
		<category><![CDATA[ragweed]]></category>

		<guid isPermaLink="false">http://nj1015.com/?p=263807</guid>
		<description><![CDATA[Drugmaker Merck &#38; Co. says the Food and Drug Administration is reviewing its second application to sell a new type of allergy treatment meant to gradually reduce allergic reactions over time, rather than just relieving sneezing, itching and other symptoms temporarily. Merck&#8217;s latest application is for an allergy immunotherapy tablet for ragweed allergies that dissolves [...]]]></description>
			<content:encoded><![CDATA[<p>Drugmaker Merck &amp; Co. says the Food and Drug Administration is reviewing its second application to sell a new type of allergy treatment meant to gradually reduce allergic reactions over time, rather than just relieving sneezing, itching and other symptoms temporarily.
<p class="more_act text"><a href="http://nj1015.com/mercks-ragweed-allergy-therapy-under-fda-review/" title="Merck&#8217;s Ragweed Allergy Therapy Under FDA Review">Read More</a><em>|</em><a href="http://nj1015.com/mercks-ragweed-allergy-therapy-under-fda-review/#comments_wrap" title="Merck&#8217;s Ragweed Allergy Therapy Under FDA Review">Comment</a></p>
]]></content:encoded>
			<wfw:commentRss>http://nj1015.com/mercks-ragweed-allergy-therapy-under-fda-review/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	<media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://wac.450F.edgecastcdn.net/80450F/nj1015.com/files/2013/05/Merck-300x225.jpg" height="225" width="300" />	</item>
		<item>
		<title>Merck: FDA Reviewing Tablet to Eliminate Allergy</title>
		<link>http://nj1015.com/merck-fda-reviewing-tablet-to-eliminate-allergy/</link>
		<comments>http://nj1015.com/merck-fda-reviewing-tablet-to-eliminate-allergy/#comments</comments>
		<pubDate>Thu, 28 Mar 2013 03:48:41 +0000</pubDate>
		<dc:creator>Townsquare News Network</dc:creator>
				<category><![CDATA[Townsquare News Network]]></category>
		<category><![CDATA[allergy pill]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[national]]></category>
		<category><![CDATA[NJ]]></category>
		<category><![CDATA[njsyndicated]]></category>

		<guid isPermaLink="false">http://nj1015.com/?p=245734</guid>
		<description><![CDATA[Drugmaker Merck &#38; Co. says federal regulators are reviewing its application to sell a new type of treatment for grass pollen allergy that gradually reduces allergy symptoms over time, rather than just temporarily relieving the sneezing and itching. The treatment, a tablet that dissolves under the tongue, could become the first alternative available in the [...]]]></description>
			<content:encoded><![CDATA[<p>Drugmaker Merck &amp; Co. says federal regulators are reviewing its application to sell a new type of treatment for grass pollen allergy that gradually reduces allergy symptoms over time, rather than just temporarily relieving the sneezing and itching.
<p class="more_act text"><a href="http://nj1015.com/merck-fda-reviewing-tablet-to-eliminate-allergy/" title="Merck: FDA Reviewing Tablet to Eliminate Allergy">Read More</a><em>|</em><a href="http://nj1015.com/merck-fda-reviewing-tablet-to-eliminate-allergy/#comments_wrap" title="Merck: FDA Reviewing Tablet to Eliminate Allergy">Comment</a></p>
]]></content:encoded>
			<wfw:commentRss>http://nj1015.com/merck-fda-reviewing-tablet-to-eliminate-allergy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	<media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://wac.450F.edgecastcdn.net/80450F/nj1015.com/files/2013/03/Merck-300x2251.jpg" height="225" width="300" />	</item>
		<item>
		<title>Merck Getting New Research and Development Director</title>
		<link>http://nj1015.com/merck-getting-new-research-and-development-director/</link>
		<comments>http://nj1015.com/merck-getting-new-research-and-development-director/#comments</comments>
		<pubDate>Fri, 08 Mar 2013 02:48:51 +0000</pubDate>
		<dc:creator>Townsquare News Network</dc:creator>
				<category><![CDATA[Townsquare News Network]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[national]]></category>
		<category><![CDATA[NJ]]></category>

		<guid isPermaLink="false">http://nj1015.com/?p=238714</guid>
		<description><![CDATA[Merck &#38; Co. is getting a new director of research and development. The world&#8217;s third-biggest drugmaker by revenue says Dr. Roger Perlmutter, a former research executive at Merck and Amgen Inc., will begin running Merck Research Laboratories on April 15. He&#8217;ll succeed Peter S. Kim, who&#8217;s overseen the labs since 2003. The two will work [...]]]></description>
			<content:encoded><![CDATA[<p>Merck &amp; Co. is getting a new director of research and development.
<p class="more_act text"><a href="http://nj1015.com/merck-getting-new-research-and-development-director/" title="Merck Getting New Research and Development Director">Read More</a><em>|</em><a href="http://nj1015.com/merck-getting-new-research-and-development-director/#comments_wrap" title="Merck Getting New Research and Development Director">Comment</a></p>
]]></content:encoded>
			<wfw:commentRss>http://nj1015.com/merck-getting-new-research-and-development-director/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	<media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://wac.450F.edgecastcdn.net/80450F/nj1015.com/files/2013/03/Merck-300x225.jpg" height="225" width="300" />	</item>
		<item>
		<title>Merck to File For Insomnia Drug Approval</title>
		<link>http://nj1015.com/merck-to-file-for-insomnia-drug-approval/</link>
		<comments>http://nj1015.com/merck-to-file-for-insomnia-drug-approval/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 22:01:37 +0000</pubDate>
		<dc:creator>Townsquare News Network</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[suvorexant]]></category>

		<guid isPermaLink="false">http://nj1015.com/?p=52449</guid>
		<description><![CDATA[Merck &#38; Co. said Monday it will file for U.S. marketing approval of its experimental insomnia drug suvorexant in 2012. Merck said late-stage studies of the effectiveness of the drug are complete and said it will seek approval from the Food and Drug Administration. Suvorexant is designed to treat insomnia without causing sleepiness the following [...]]]></description>
			<content:encoded><![CDATA[<p>Merck &amp; Co. said Monday it will file for U.S. marketing approval of its experimental insomnia drug suvorexant in 2012.
<p class="more_act text"><a href="http://nj1015.com/merck-to-file-for-insomnia-drug-approval/" title="Merck to File For Insomnia Drug Approval">Read More</a><em>|</em><a href="http://nj1015.com/merck-to-file-for-insomnia-drug-approval/#comments_wrap" title="Merck to File For Insomnia Drug Approval">Comment</a></p>
]]></content:encoded>
			<wfw:commentRss>http://nj1015.com/merck-to-file-for-insomnia-drug-approval/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	<media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://wac.450F.edgecastcdn.net/80450F/nj1015.com/files/2012/02/Merck.jpg" height="465" width="620" /><media:description xmlns:media="http://search.yahoo.com/mrss/">Getty Images</media:description>	</item>
	</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Page Caching using memcached
Object Caching 1142/1268 objects using memcached
Content Delivery Network via wac.450F.edgecastcdn.net/80450F/nj1015.com

Served from: nj1015.com @ 2013-06-19 23:35:54 -->